
Journal of Organic Chemistry p. 8723 - 8731 (2020)
Update date:2022-08-03
Topics:
Li, Junlan
Liu, Lihua
Zheng, Kaiting
Zheng, Chenggong
Xiao, Hua
Fan, Shilu
The incorporation of a perfluoroalkyl group (RF) into drug candidates has become an increasingly important strategy in drug molecule design. In this study, the silver-mediated perfluoroalkylation reaction based on the addition-elimination process of terminal alkynes which was initiated by a perfluoroalkyl radical to form a C(sp)-RF bond has been developed. The reaction proceeds under mild conditions using readily available, low-cost perfluoroalkyl iodides as the sources of the RF group. This method allows access to a variety of perfluoroalkylated alkynes.
Shenzhen ZheYi Chemicals Co.,LTD(Shanghai Branch)
Contact:+86-21-54159691
Address:Room1002,Building No.2, Lane 98 Bixiu Road,Minhang District, Shanghai,China 201100
Contact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
Yurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Doi:10.1139/v74-205
(1974)Doi:10.1021/jo00938a010
(1974)Doi:10.1021/ja00339a017
(1983)Doi:10.1002/ejic.200390019
(2003)Doi:10.1021/jo00256a014
(1988)Doi:10.1021/ja00008a058
(1991)